SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Burzynski Research Institute Inc – ‘10-Q’ for 8/31/12 – ‘EX-101.SCH’

On:  Monday, 10/15/12, at 5:05pm ET   ·   For:  8/31/12   ·   Accession #:  1104659-12-69167   ·   File #:  0-23425

Previous ‘10-Q’:  ‘10-Q’ on 7/16/12 for 5/31/12   ·   Next:  ‘10-Q’ on 1/14/13 for 11/30/12   ·   Latest:  ‘10-Q’ on 1/16/24 for 11/30/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/15/12  Burzynski Research Institute Inc  10-Q        8/31/12   31:1.6M                                   Toppan Merrill/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report Pursuant to Sections 13 or 15(D)   HTML    236K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     18K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     17K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     14K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     14K 
21: R1          Document and Entity Information                     HTML     33K 
15: R2          Balance Sheets                                      HTML     63K 
19: R3          Balance Sheets (Parenthetical)                      HTML     28K 
22: R4          Statements of Operations                            HTML     43K 
29: R5          Statement of Stockholders' Deficit                  HTML     28K 
17: R6          Statements of Cash Flows                            HTML     53K 
18: R7          Basis of Presentation                               HTML     25K 
14: R8          Economic Dependency                                 HTML     27K 
12: R9          Stock Options and Warrants                          HTML     28K 
30: R10         Loss Per Share                                      HTML     17K 
24: R11         Income Taxes                                        HTML     57K 
23: R12         Stock Options (Tables)                              HTML     19K 
26: R13         Income Taxes (Tables)                               HTML     51K 
27: R14         Basis of Presentation (Details)                     HTML     13K 
25: R15         Stock Options and Warrants (Details)                HTML     45K 
28: R16         Loss Per Share (Details)                            HTML     18K 
20: R17         Income Taxes (Details)                              HTML     49K 
31: XML         IDEA XML File -- Filing Summary                      XML     38K 
13: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    159K 
 6: EX-101.INS  XBRL Instance -- bzyr-20120831                       XML    237K 
 8: EX-101.CAL  XBRL Calculations -- bzyr-20120831_cal               XML     57K 
 9: EX-101.DEF  XBRL Definitions -- bzyr-20120831_def                XML    168K 
10: EX-101.LAB  XBRL Labels -- bzyr-20120831_lab                     XML    557K 
11: EX-101.PRE  XBRL Presentations -- bzyr-20120831_pre              XML    275K 
 7: EX-101.SCH  XBRL Schema -- bzyr-20120831                         XSD     55K 
16: ZIP         XBRL Zipped Folder -- 0001104659-12-069167-xbrl      Zip     45K

‘EX-101.SCH’   —   XBRL Schema — bzyr-20120831

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Created by Merrill Corporation -->
<!-- Generated by Fujitsu Interstage XWand B0166_M01 -->
<xsd:schema targetNamespace="http://www.burzynskiresearch.com/20120831" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:bzyr="http://www.burzynskiresearch.com/20120831" xmlns:us-types="http://fasb.org/us-types/2012-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:attributeFormDefault="unqualified" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:xlink="http://www.w3.org/1999/xlink">
<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:type="simple" xlink:href="bzyr-20120831_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="bzyr-20120831_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="bzyr-20120831_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="bzyr-20120831_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
<link:definition> 0000 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/BalanceSheet" id="BalanceSheet">
<link:definition> 0010 - Statement - BALANCE SHEETS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/BalanceSheetParenthetical" id="BalanceSheetParenthetical">
<link:definition> 0015 - Statement - BALANCE SHEETS (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/StatementOfIncome" id="StatementOfIncome">
<link:definition> 0020 - Statement - STATEMENTS OF OPERATIONS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/StatementOfStockholdersEquity" id="StatementOfStockholdersEquity">
<link:definition> 0030 - Statement - STATEMENT OF STOCKHOLDERS' DEFICIT </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/CashFlows" id="CashFlows">
<link:definition> 0040 - Statement - STATEMENTS OF CASH FLOWS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureBasisOfPresentation" id="DisclosureBasisOfPresentation">
<link:definition> 1010 - Disclosure - BASIS OF PRESENTATION </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureEconomicDependency" id="DisclosureEconomicDependency">
<link:definition> 1020 - Disclosure - ECONOMIC DEPENDENCY </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureStockOptionsAndWarrants" id="DisclosureStockOptionsAndWarrants">
<link:definition> 1030 - Disclosure - STOCK OPTIONS AND WARRANTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
<link:definition> 1050 - Disclosure - INCOME TAXES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureStockOptionsTables" id="DisclosureStockOptionsTables">
<link:definition> 3030 - Disclosure - STOCK OPTIONS (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
<link:definition> 3050 - Disclosure - INCOME TAXES (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureBasisOfPresentationDetails" id="DisclosureBasisOfPresentationDetails">
<link:definition> 4010 - Disclosure - BASIS OF PRESENTATION (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureStockOptionsAndWarrantsDetails" id="DisclosureStockOptionsAndWarrantsDetails">
<link:definition> 4030 - Disclosure - STOCK OPTIONS AND WARRANTS (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureIncomeTaxesDetails" id="DisclosureIncomeTaxesDetails">
<link:definition> 4050 - Disclosure - INCOME TAXES (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosurePropertyAndEquipment" id="DisclosurePropertyAndEquipment">
<link:definition> 8000 - Disclosure - Property and Equipment: </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureEmployeeBenefits" id="DisclosureEmployeeBenefits">
<link:definition> 8010 - Disclosure - Employee Benefits: </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureLeaseCommitments" id="DisclosureLeaseCommitments">
<link:definition> 8020 - Disclosure - Lease commitments: </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureAgreementsWithAndOtherRelatedPartyTransactions" id="DisclosureAgreementsWithAndOtherRelatedPartyTransactions">
<link:definition> 8030 - Disclosure - Agreements With, and Other Related Party Transactions: </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureCommitmentsAndContingenciesAndSupplySource" id="DisclosureCommitmentsAndContingenciesAndSupplySource">
<link:definition> 8040 - Disclosure - Commitments and Contingencies and Supply Source: </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
<link:definition> 8050 - Disclosure - SUBSEQUENT EVENTS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureEarningsPerShare" id="DisclosureLossPerShare">
<link:definition> 1040 - Disclosure - LOSS PER SHARE </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.burzynskiresearch.com/role/DisclosureLossPerShareDetails" id="DisclosureLossPerShareDetails">
<link:definition> 4040 - Disclosure - LOSS PER SHARE (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:import namespace="http://fasb.org/us-gaap/2012-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2012-01-31" schemaLocation="http://xbrl.sec.gov/dei/2012/dei-2012-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://fasb.org/us-types/2012-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2012/elts/us-types-2012-01-31.xsd"/>
<xsd:element name="IncomeTaxExaminationPeriodAfterFilingIncomeTaxReturnsSubjectToExamination" id="bzyr_IncomeTaxExaminationPeriodAfterFilingIncomeTaxReturnsSubjectToExamination" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="DocumentAndEntityInformationAbstract" id="bzyr_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="AdjustmentsToAdditionalPaidInCapitalCashContributed" id="bzyr_AdjustmentsToAdditionalPaidInCapitalCashContributed" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element name="AdjustmentsToAdditionalPaidInCapitalClinicalTrialExpenses" id="bzyr_AdjustmentsToAdditionalPaidInCapitalClinicalTrialExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element name="ClinicalTrialExpensesPaid" id="bzyr_ClinicalTrialExpensesPaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element name="CashPaidDuringTheYearFor" id="bzyr_CashPaidDuringTheYearFor" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="OwnershipInterestPercentageHeldByCompanyPresidentAndChairmanOfBoard" id="bzyr_OwnershipInterestPercentageHeldByCompanyPresidentAndChairmanOfBoard" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant"/>
<xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" id="bzyr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" type="xbrli:integerItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod" id="bzyr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPeriodForWhichAwardsIncreaseProportionatelyToNewIssues" id="bzyr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPeriodForWhichAwardsIncreaseProportionatelyToNewIssues" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="WorldwideMedicalConsultantsIncMember" id="bzyr_WorldwideMedicalConsultantsIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="CarigenLtdMember" id="bzyr_CarigenLtdMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="PercentageOfConsultingFeeToBeReceivedAsPerAgreement" id="bzyr_PercentageOfConsultingFeeToBeReceivedAsPerAgreement" type="num:percentItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="ClassOfWarrantOrRightNumberOfSecuritiesToBeCalledByWarrantsOrRightsWMCPaymentConsideration" id="bzyr_ClassOfWarrantOrRightNumberOfSecuritiesToBeCalledByWarrantsOrRightsWMCPaymentConsideration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="ClassOfWarrantOrRightsExercisePeriod" id="bzyr_ClassOfWarrantOrRightsExercisePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="SharesVestingUponExecutionOfAgreement" id="bzyr_SharesVestingUponExecutionOfAgreement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="RemainingSharesToVestUponFirstClosingOfAgreement" id="bzyr_RemainingSharesToVestUponFirstClosingOfAgreement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="MarketingAgreementAbstract" id="bzyr_MarketingAgreementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
<xsd:element name="WarrantsOrRightsFairValue" id="bzyr_WarrantsOrRightsFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element name="WarrantOrRightFairValuePerWarrant" id="bzyr_WarrantOrRightFairValuePerWarrant" type="us-types:perUnitItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="instant"/>
</xsd:schema>

↑Top
Filing Submission 0001104659-12-069167   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Wed., Apr. 24, 9:03:34.1pm ET